Companies to integrate Emerson’s DeltaV distributed control system
with GE’s technologies for manufacture of monoclonal antibodies,
vaccines and other biologics
Collaboration will help drive improvements in productivity
GE
Healthcare’s Life Sciences business and Emerson
Process Management, a global business of Emerson
(NYSE: EMR), today announced a collaboration aimed at increasing
productivity and improving efficiency in the production of
biopharmaceuticals such as monoclonal antibodies and vaccines. The two
companies will collaborate to integrate Emerson’s DeltaV™ distributed
control system with GE Healthcare’s enterprise offerings and
start-to-finish technologies for the global biomanufacturing industry.
The first DeltaV-driven GE Healthcare installation, which is expected to
be complete before the end of the year, will be a FlexFactory™,
GE’s integrated manufacturing platform based on single-use technologies.
Biopharmaceutical manufacturers are increasingly looking to automate
production processes, driven by the industry need to increase efficiency
and reduce costs. GE’s start-to-finish portfolio of single-use
bioprocessing technologies already allows manufacturers to reduce set-up
times and increase manufacturing flexibility. Emerson’s DeltaV system,
which uses predictive technologies to connect people, processes and
production, enables remote monitoring and control from multiple
locations across a company’s network and is already widely used in the
pharmaceutical industry. The DeltaV system will be offered as an
automation control platform for GE’s single-use bioprocessing offerings.
Emmanuel Ligner, Global Commercial Manager, BioProcess, GE Healthcare
Life Sciences, said: “Healthcare providers and the biopharmaceutical
industry are facing enormous pressures. Emerson and GE share a vision
that an integrated and automated approach to manufacturing has the
potential to help drive improvements in production efficiency of these
life-saving medicines. This collaboration with Emerson, combined with
our depth and breadth of expertise in start-to-finish technologies for
bioprocessing, promises to bring real benefits to our customers and to
healthcare providers worldwide.”
”We believe that the combination of Emerson’s automation technologies
and the GE FlexFactory will offer superior process performance,
consistency of product, and reduced validation time,” said Jerry Brown,
senior vice president of industry solutions for Emerson Process
Management. “This collaboration will support more predictable processes
that eliminate unnecessary work, which translates into a reduced time to
market for our customers.”
About GE Healthcare
GE Healthcare provides transformational medical technologies and
services to meet the demand for increased access, enhanced quality and
more affordable healthcare around the world. GE (NYSE: GE) works on
things that matter - great people and technologies taking on tough
challenges. From medical imaging, software & IT, patient monitoring and
diagnostics to drug discovery, biopharmaceutical manufacturing
technologies and performance improvement solutions, GE Healthcare helps
medical professionals deliver great healthcare to their patients. For
more information about GE Healthcare, visit our website at www.gehealthcare.com.
About Emerson Process Management
Emerson Process Management (www.EmersonProcess.com),
an Emerson business, is a leader in helping businesses automate their
production, processing and distribution in the chemical, oil and gas,
refining, pulp and paper, power, water and wastewater treatment, mining
and metals, food and beverage, life sciences and other industries. The
company combines superior products and technology with industry-specific
engineering, consulting, project management and maintenance services.
Its brands include Bettis™, DeltaV™, Fisher™, Micro Motion™, Ovation™
and Rosemount™.
About Emerson
Emerson (NYSE: EMR), based in St. Louis, Missouri (USA), is a global
leader in bringing technology and engineering together to provide
innovative solutions for customers in industrial, commercial, and
consumer markets around the world. The company is comprised of five
business segments: Process Management, Industrial Automation, Network
Power, Climate Technologies, and Commercial & Residential Solutions.
Sales in fiscal 2015 were $22.3 billion. For more information, visit Emerson.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20151116005048/en/
Copyright Business Wire 2015